NuVision Biotherapies raised €1.2M in a funding round in Mar 2023. The company is based in Nottingham, UK. Investors in the round: MEIF Proof of Concept & Early Stage Fund, Mercia’s EIS Funds, Midlands Engine Investment Fund and 2 others. Data as of Nov 2026.
Amount raised
€1.2M
€1,238,543
Native amount
1,100,000 GBP
Stage
Other
funding round
Investors
5
Provenance & confidence
High confidenceAmount
1,100,000 GBP
ECB-at-date → €1.2M · rate 0.88814 on 2023-03-09
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
5 namedMEIF Proof of Concept & Early Stage FundMercia’s EIS FundsMidlands Engine Investment FundPioneer FundUniversity of Nottingham
Date
Mar 2023
Round type
funding round
Amount (EUR)
€1.2M
Other rounds
same companyRelated news
- NuVision Raises Further £1.1M in Fundingfinsmes.com · 2023-03